Down SyndromeNCT05995223
Oxygen Uptake Kinetics During Submaximal Exercise in Adults With Down Syndrome
A study testing Submaximal exercise protocol in people with Down Syndrome, run by University of Nevada, Las Vegas at 1 site in United States.
Trial summary
This study aims to compare the rate at which oxygen uptake adapts to submaximal, moderate intensity exercise (oxygen uptake kinetics) between adults with and without Down syndrome, to determine the contribution of oxygen uptake kinetics to exercise intolerance of adults with Down syndrome. Read more about this study
- Who is it for?
- Ages 18 to 35 yearsHealthy volunteers can take part
- Conditions the study is for
- Down Syndrome
- What is being tested?
- Submaximal exercise protocol
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 28 participants
- Where
- 1 siteUnited States
- Study dates
- 4 Oct 2023to 27 Jun 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 35 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- low active (defined as being involved in less than 30 minutes of moderately-intense physical activity per day);
- diagnosis with Down syndrome trisomy 21 (Down syndrome group only);
- normal thyroid function or stable thyroid function (with medications) for at least 6 months (Down syndrome group only).
Who cannot join
- asthma or other pulmonary disease;
- severe obesity (defined as BMI >40);
- uncontrolled hypertension (defined as blood pressure >130/80 mmHg);
- congenital heart disease;
- diabetes (defined as Hba1c of >7.5% or use of glucose lowering medication);
- current smoking;
- pregnancy.
Trial locations and contacts
1 site in 1 country.
United States1 site
University of Nevada, Las Vegas
Las Vegas, Nevada, 89154
About this study
This study aims to compare the rate at which oxygen uptake adapts to submaximal, moderate intensity exercise (oxygen uptake kinetics) between adults with and without Down syndrome, to determine the contribution of oxygen uptake kinetics to exercise intolerance of adults with Down syndrome. Additionally, the study will investigate the role of oxygen delivery (by the cardiovascular circuit) and oxygen utilization (in the mitochondria) on the oxygen uptake kinetics of adults with Down syndrome to identify specific areas which adults with Down syndrome could benefit from targeting during exercise training. Overall, this study aims to contribute to the knowledge on the exercise capacity of adults with Down syndrome, in order to improve the way adults with Down syndrome participate in and benefit from exercise.
Participants will perform a maximal exercise test on a treadmill, and walk on a treadmill at a submaximal, moderate intensity speed and incline, during which oxygen uptake at the lungs, cardiac output, and oxygen utilization in the muscle will be measured.
Read the detailed description
Down syndrome (Ds) is the most common chromosomal disorder, affecting approximately 1 in every 800 live births in the US. In addition to a number of comorbidities, individuals with Ds have low cardiorespiratory fitness. Their low fitness cannot be explained by low levels of physical activity, lack of motivation, or lack of understanding of the test, but rather has a physiological cause. Autonomic dysfunction has been identified as one major contributor to the low cardiorespiratory fitness in individuals with Ds, but it does not fully explain the phenomenon.
Cardiorespiratory fitness is determined by the capacity of the body to produce energy, which largely relies on the ability to take up, deliver, and use oxygen. This process of oxygen transport is governed by the pulmonary, cardiovascular, and muscular system, and the degree to which they work together. At the start of exercise, these three systems respond in a delayed pattern, requiring the body to compensate energy production through anaerobic means, which negatively affect one's exercise tolerance. Thus, the quicker the adaptation of these three systems (i.e. the quicker their kinetics), the better one's ability to perform and tolerate exercise.
The rate of adaption of these oxygen transport system can be quantified by assessing oxygen uptake (pulmonary), cardiac output (cardiovascular), and mitochondrial oxygen utilization (muscle) kinetics, which all show a delayed, exponential increase towards steady state at the start of moderate intensity exercise. The kinetics of these three systems have never been assessed in individuals with Ds, and could provide valuable insights into their low cardiorespiratory fitness and reduced exercise tolerance.
The aim of this research proposal is therefore to determine the differences in kinetics of oxygen uptake, cardiac output, and mitochondrial oxygen utilization between individuals with and without Ds to better understand the underlying physiology and potentially improve healthy by using this knowledge for exercise interventions.
Overall aim: to better understand the relation between oxygen uptake kinetics and cardiorespiratory fitness in individuals with Ds.
Aim 1: To compare the rate of oxygen uptake, cardiac output, and mitochondrial oxygen utilization kinetics in response to submaximal, moderate intensity exercise between adults with and without Ds.
Aim 2: To determine the relation between the rate of oxygen uptake kinetics and the peak oxygen uptake of individuals with Ds.
Determining how oxygen transport affects individuals with Ds during exercise could potentially give more direction into designing exercise sessions and interventions, as their oxygen transport system potentially might need more time to reach the required working level.
General study design. Participants will complete two study visits, during which their cardiorespiratory capacities will be tested using two different treadmill protocols. Familiarization with all study personnel and procedures will take place before actual measurements are performed.
Description data collection visits. Participants will be tested in a postprandial state (>3 h) on 2 separate days (separated by at least 48 hours, but no more than 2 weeks) and will refrain from exercise, alcohol and caffeine for at least 24 h before each study visit. During the first visit, height, weight, and circumferences will be measured. Body composition will be measured using dual energy X-ray absorptiometry (DEXA), and echocardiography will be performed to determined aortic diameter and to screen for any potential residual cardiac deficits common in individuals with Ds. Lastly, participants will perform a graded maximal treadmill exercise test to determine peak oxygen uptake (VO2peak) and to determine the submaximal exercise intensity for the second visit.
The second visit will have participants walk on an intensity associated with 80% of their ventilatory threshold for six minutes while pulmonary oxygen uptake (using breath-by-breath gas exchange analysis), cardiac output (using beat-to-beat blood pressure measurement), and muscle oxygenation (using near-infrared spectroscopy (NIRS)) is measured. This bout of six minutes will be repeated four times, with 10 minutes rest in between. The four bouts will be used to average the three signals, which improves the calculation of kinetic parameters.
Familiarization. Parents/care givers are involved in order to provide a supportive environment for participants and to enhance the parent/caregiver understanding of the research. Prior to study initiation, photographs and video clips of the laboratory and study equipment will be provided to help the participants become comfortable with the laboratory environment and equipment, and the informed consent information is sent to the participants and their parents/care-givers for their review. Familiarization for the participants with Down syndrome will be divided in two parts: they will practice and become accustomed with the treadmill and the equipment for the graded maximal exercise test (very start of the first visit), and they will practice and become accustomed with the procedures for the submaximal exercise protocol (start of the second visit).
- Conditions
- Down Syndrome
- Being tested
- Submaximal exercise protocol
- Keywords
- Down syndrome, cardiorespiratory fitness, oxygen uptake, cardiac output, mitochondrial oxygen utilization
- Medical subject headings
- Down Syndrome
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Submaximal exercise protocolOther
Participants will complete a submaximal walking protocol on a motorized treadmill, which consists of 4 times 6 minutes of walking at a moderate intensity speed and incline while their breathing, cardiac output, and muscle oxygen use is measured, with 10 minutes rest in between each bout.
| Study group | Role | What they receive |
|---|---|---|
| Down syndrome | Experimental | Participants will complete a submaximal walking protocol on a motorized treadmill, which consists of 4 times 6 minutes of walking at a moderate intensity speed and incline while their breathing, cardiac output, and muscle oxygen use is measured, with 10 minutes rest in between each bout. Receives: Other: Submaximal exercise protocol |
| control without Down syndrome | Experimental | This group of age- and sex-matched participants without Down syndrome will undergo the same testing as participants with Down syndrome Receives: Other: Submaximal exercise protocol |
What is being measured
The primary outcome is the main question the study is designed to answer.
Oxygen uptake kinetics
The finite rate at which oxygen uptake (measured with breath-by-breath gas exchange analysis at the mouth) adapts to a (submaximal) increase in exercise intensity, primarily captured by time constant tau, which describes the time needed to reach 63% of the required, steady state oxygen uptake
Measured: Through study completion, on average 4 hours
Secondary outcomes (13)
Cardiac output kinetics
The finite rate at which cardiac output (calculated from beat-to-beat blood pressure waves) adapts to a (submaximal) increase in exercise intensity, primarily captured by time constant tau, which describes the time needed to reach 63% of the required, steady state cardiac output
Measured: Through study completion, on average 4 hours
Muscle deoxygenation kinetics
The finite rate at which muscle oxygen utilization (measured as the production of deoxyhemoglobin at the muscle) adapts to a (submaximal) increase in exercise intensity, primarily captured by time constant tau, which describes the time needed to reach 63% of the required, steady state muscle oxygen utilization
Measured: Through study completion, on average 4 hours
Steady-state cardiac output
Steady state cardiac output during standing rest and submaximal exercise (in L/min)
Measured: Through study completion, on average 4 hours
Absolute peak oxygen uptake
Peak oxygen uptake (VO2peak; expressed in L/min)
Measured: Through study completion, on average 4 hours
Relative peak oxygen uptake (corrected for total body mass)
Peak oxygen uptake (VO2peak; expressed in ml/kg/min)
Measured: Through study completion, on average 4 hours
Relative peak oxygen uptake (corrected for lean body mass)
Peak oxygen uptake (VO2peak; expressed in L=mL/kg lean body mass/min)
Measured: Through study completion, on average 4 hours
Ventilatory threshold (L/min)
The threshold where ventilation starts to increase at a faster rate than oxygen uptake during a graded maximal exercise test (expressed in L/min)
Measured: Through study completion, on average 4 hours
Ventilatory threshold (%VO2peak)
The threshold where ventilation starts to increase at a faster rate than oxygen uptake during a graded maximal exercise test (expressed as a percentage of VO2peak)
Measured: Through study completion, on average 4 hours
Stroke volume
Stroke volume (mL)
Measured: Through study completion, on average 4 hours
Heart rate
Heart rate (in bpm)
Measured: Through study completion, on average 4 hours
Oxygen uptake efficiency slope
The slope between oxygen uptake (L/min) and the common logarithm of minute ventilation (L/min) during a graded maximal exercise test
Measured: Through study completion, on average 4 hours
Ve/VCO2 slope
The slope between minute ventilation (Ve; L/min) and carbon dioxide production (VCO2; L/min) during a graded maximal exercise test
Measured: Through study completion, on average 4 hours
Lean body mass
Lean body mass determined with Dual Energy X-ray Absorptiometry (DXA) scan in kg
Measured: Through study completion, on average 4 hours
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Aug 2023
- Study start4 Oct 2023
- Primary completion27 Jun 2024
- Study completion27 Jun 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Down SyndromeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Screening
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 28 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Nevada, Las Vegas
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Victor Beck, University of Nevada, Las Vegas
- Investigators
- Victor DY Beck, MS, Principal investigator, University of Nevada, Las Vegas
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05995223
- Sponsor's protocol ID
- UNLV-2022-489
- Status last verified
- Jun 2024
- First submitted
- 29 Jun 2023
- Last updated
- 1 Jul 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: De-identified IPD will be made available to other researchers upon request.
Study at a glance
From the registry record, last updated by the sponsor on 1 Jul 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Oxygen Uptake Kinetics During Submaximal Exercise in Adults With Down Syndrome
- ClinicalTrials.gov ID
- NCT05995223
- Acronym / sponsor ID
- UNLV-2022-489
- Conditions
- Down Syndrome
- Keywords
- Down syndrome, cardiorespiratory fitness, oxygen uptake, cardiac output, mitochondrial oxygen utilization
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 28 participants (actual)
- Lead sponsor
- University of Nevada, Las VegasUniversity, hospital or other
- Study start
- 4 Oct 2023 (actual)
- Primary completion
- 27 Jun 2024 (actual)
- Study completion
- 27 Jun 2024 (actual)
- First posted
- 16 Aug 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to compare the rate at which oxygen uptake adapts to submaximal, moderate intensity exercise (oxygen uptake kinetics) between adults with and without Down syndrome, to determine the contribution of oxygen uptake kinetics to exercise intolerance of adults with Down syndrome. Additionally, the study will investigate the role of oxygen delivery (by the cardiovascular circuit) and oxygen utilization (in the mitochondria) on the oxygen uptake kinetics of adults with Down syndrome to identify specific areas which adults with Down syndrome could benefit from targeting during exercise training. Overall, this study aims to contribute to the knowledge on the exercise capacity of adults with Down syndrome, in order to improve the way adults with Down syndrome participate in and benefit from exercise.
Participants will perform a maximal exercise test on a treadmill, and walk on a treadmill at a submaximal, moderate intensity speed and incline, during which oxygen uptake at the lungs, cardiac output, and oxygen utilization in the muscle will be measured.
Detailed description
Down syndrome (Ds) is the most common chromosomal disorder, affecting approximately 1 in every 800 live births in the US. In addition to a number of comorbidities, individuals with Ds have low cardiorespiratory fitness. Their low fitness cannot be explained by low levels of physical activity, lack of motivation, or lack of understanding of the test, but rather has a physiological cause. Autonomic dysfunction has been identified as one major contributor to the low cardiorespiratory fitness in individuals with Ds, but it does not fully explain the phenomenon.
Cardiorespiratory fitness is determined by the capacity of the body to produce energy, which largely relies on the ability to take up, deliver, and use oxygen. This process of oxygen transport is governed by the pulmonary, cardiovascular, and muscular system, and the degree to which they work together. At the start of exercise, these three systems respond in a delayed pattern, requiring the body to compensate energy production through anaerobic means, which negatively affect one's exercise tolerance. Thus, the quicker the adaptation of these three systems (i.e. the quicker their kinetics), the better one's ability to perform and tolerate exercise.
The rate of adaption of these oxygen transport system can be quantified by assessing oxygen uptake (pulmonary), cardiac output (cardiovascular), and mitochondrial oxygen utilization (muscle) kinetics, which all show a delayed, exponential increase towards steady state at the start of moderate intensity exercise. The kinetics of these three systems have never been assessed in individuals with Ds, and could provide valuable insights into their low cardiorespiratory fitness and reduced exercise tolerance.
The aim of this research proposal is therefore to determine the differences in kinetics of oxygen uptake, cardiac output, and mitochondrial oxygen utilization between individuals with and without Ds to better understand the underlying physiology and potentially improve healthy by using this knowledge for exercise interventions.
Overall aim: to better understand the relation between oxygen uptake kinetics and cardiorespiratory fitness in individuals with Ds.
Aim 1: To compare the rate of oxygen uptake, cardiac output, and mitochondrial oxygen utilization kinetics in response to submaximal, moderate intensity exercise between adults with and without Ds.
Aim 2: To determine the relation between the rate of oxygen uptake kinetics and the peak oxygen uptake of individuals with Ds.
Determining how oxygen transport affects individuals with Ds during exercise could potentially give more direction into designing exercise sessions and interventions, as their oxygen transport system potentially might need more time to reach the required working level.
General study design. Participants will complete two study visits, during which their cardiorespiratory capacities will be tested using two different treadmill protocols. Familiarization with all study personnel and procedures will take place before actual measurements are performed.
Description data collection visits. Participants will be tested in a postprandial state (>3 h) on 2 separate days (separated by at least 48 hours, but no more than 2 weeks) and will refrain from exercise, alcohol and caffeine for at least 24 h before each study visit. During the first visit, height, weight, and circumferences will be measured. Body composition will be measured using dual energy X-ray absorptiometry (DEXA), and echocardiography will be performed to determined aortic diameter and to screen for any potential residual cardiac deficits common in individuals with Ds. Lastly, participants will perform a graded maximal treadmill exercise test to determine peak oxygen uptake (VO2peak) and to determine the submaximal exercise intensity for the second visit.
The second visit will have participants walk on an intensity associated with 80% of their ventilatory threshold for six minutes while pulmonary oxygen uptake (using breath-by-breath gas exchange analysis), cardiac output (using beat-to-beat blood pressure measurement), and muscle oxygenation (using near-infrared spectroscopy (NIRS)) is measured. This bout of six minutes will be repeated four times, with 10 minutes rest in between. The four bouts will be used to average the three signals, which improves the calculation of kinetic parameters.
Familiarization. Parents/care givers are involved in order to provide a supportive environment for participants and to enhance the parent/caregiver understanding of the research. Prior to study initiation, photographs and video clips of the laboratory and study equipment will be provided to help the participants become comfortable with the laboratory environment and equipment, and the informed consent information is sent to the participants and their parents/care-givers for their review. Familiarization for the participants with Down syndrome will be divided in two parts: they will practice and become accustomed with the treadmill and the equipment for the graded maximal exercise test (very start of the first visit), and they will practice and become accustomed with the procedures for the submaximal exercise protocol (start of the second visit).
Study design
- Primary purpose
- Screening
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Down syndrome | Experimental | Other: Submaximal exercise protocolParticipants will complete a submaximal walking protocol on a motorized treadmill, which consists of 4 times 6 minutes of walking at a moderate intensity speed and incline while their breathing, cardiac output, and muscle oxygen use is measured, with 10 minutes rest in between each bout. |
| control without Down syndrome | Experimental | Other: Submaximal exercise protocolThis group of age- and sex-matched participants without Down syndrome will undergo the same testing as participants with Down syndrome |
Who may qualify
- Ages
- 18 to 35 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- low active (defined as being involved in less than 30 minutes of moderately-intense physical activity per day);
- diagnosis with Down syndrome trisomy 21 (Down syndrome group only);
- normal thyroid function or stable thyroid function (with medications) for at least 6 months (Down syndrome group only).
Key exclusion criteria (7 listed)
- asthma or other pulmonary disease;
- severe obesity (defined as BMI >40);
- uncontrolled hypertension (defined as blood pressure >130/80 mmHg);
- congenital heart disease;
- diabetes (defined as Hba1c of >7.5% or use of glucose lowering medication);
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Submaximal exercise protocolParticipants will complete a submaximal walking protocol on a motorized treadmill, which consists of 4 times 6 minutes of walking at a moderate intensity speed and incline while their breathing, cardiac output, and muscle oxygen use is measured, with 10 minutes rest in between each bout. | Other | Down syndrome, control without Down syndrome |
Primary outcome
Oxygen uptake kinetics
Time frame: Through study completion, on average 4 hours
The finite rate at which oxygen uptake (measured with breath-by-breath gas exchange analysis at the mouth) adapts to a (submaximal) increase in exercise intensity, primarily captured by time constant tau, which describes the time needed to reach 63% of the required, steady state oxygen uptake
13 secondary outcomes
Cardiac output kinetics
Time frame: Through study completion, on average 4 hours
Muscle deoxygenation kinetics
Time frame: Through study completion, on average 4 hours
Steady-state cardiac output
Time frame: Through study completion, on average 4 hours
Absolute peak oxygen uptake
Time frame: Through study completion, on average 4 hours
Relative peak oxygen uptake (corrected for total body mass)
Time frame: Through study completion, on average 4 hours
Relative peak oxygen uptake (corrected for lean body mass)
Time frame: Through study completion, on average 4 hours
Ventilatory threshold (L/min)
Time frame: Through study completion, on average 4 hours
Ventilatory threshold (%VO2peak)
Time frame: Through study completion, on average 4 hours
Stroke volume
Time frame: Through study completion, on average 4 hours
Heart rate
Time frame: Through study completion, on average 4 hours
Oxygen uptake efficiency slope
Time frame: Through study completion, on average 4 hours
Ve/VCO2 slope
Time frame: Through study completion, on average 4 hours
Lean body mass
Time frame: Through study completion, on average 4 hours
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Jul 2024.
- Individual participant dataSharing planned: No. De-identified IPD will be made available to other researchers upon request.
Related trials for Down Syndrome
RecruitingObservational study
Natural History of Dysregulation and Aging of the Immune System in People With Trisomy 21 With and Without Thymectomy
Down Syndrome
RecruitingPhase 2
Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
Atopic Dermatitis, Alopecia Areata
RecruitingObservational study
Kinematic Analysis of Manual Dexterity
Down Syndrome, Hemiparesis
RecruitingObservational study
The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk Assessment
Pregnant Individuals, Aneuploidy
RecruitingPhase 3
Exploring Sympathetic Nervous System Function in Individuals With Down Syndrome
Down Syndrome, Autonomic Dysfunction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Victor DY Beck, MS principal investigator
University of Nevada, Las Vegas
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Submaximal exercise protocol in people with Down Syndrome, run by University of Nevada, Las Vegas at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Oxygen uptake kinetics (time frame: Through study completion, on average 4 hours). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jul 2024.